Internal Medicine, Medical Oncology · San Francisco, CA
NPI
1326058777
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1600 Divisadero St, 4th Floor, Box 1705
San Francisco, CA, 94115
Phone (415) 353-9888
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
871 services
Medicare patients, 2024
115
Average age 71
Drug cost, 2024
$820K
190 prescriptions
Company payments, 2025
$0
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chloe Atreya was code 99215 (office e&m - established), 219 times for 85 patients. In total Chloe Atreya billed 871 services in 12 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 219 | 85 | $125.98 | $28K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 65 | 41 | $14.78 | $961 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 44 | 22 | $27.90 | $1,228 |
| 99205 Office E&M - New | Facility | 23 | 23 | $161.09 | $3,705 |
| 99214 Office E&M - Established | Facility | 12 | 11 | $86.87 | $1,042 |
By year: 2022 $36K for 380 services; 2023 $26K for 256 services; 2024 $36K for 871 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chloe Atreya prescribed most often to Medicare patients was Lonsurf (Trifluridine/Tipiracil Hcl), with 43 prescriptions and refills. In total Chloe Atreya wrote 190 Medicare prescriptions that cost $820K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lonsurf Trifluridine/Tipiracil Hcl | 43 | 43 | Under 11 | $399K |
| Sunitinib Malate Generic | 25 | 26 | Under 11 | $113K |
| Prochlorperazine Maleate Generic | 24 | 24 | Under 11 | $163 |
| Ondansetron Hcl Generic | 20 | 20 | 13 | $313 |
| Eliquis Apixaban | 13 | 23 | Under 11 | $13K |
Brand drugs: 78 claims; generic drugs: 112 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chloe Atreya $0 (- in general payments such as food, travel and fees) from 2 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.